Covaxin effective against Delta Plus variant, says ICMR study
COVAXIN is effective against Delta Plus variant of COVID-19, quoting medical body ICMR, as saying. Covaxin was developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) and its subsidiary National Institute of Virology (NIV).
READ MORE:
Other Biotech Videos
AI in Pharma: How India's Drug Giants Are Betting Big on Artificial Intelligence
USV | Take heart: Steering preventive strategies for charting a journey towards cardiac wellness
Beat Diabetes With Lifestyle Modification
Serum to double investment in Biocon's unit to $300 mn; aim to generate higher EBITDA going ahead: Kiran Mazumdar-Shaw
India is stepping up genome sequencing of COVID 19 positive samples amid growing outbreaks in China, Japan and South Korea
